___

• Eldar-Finkelman H, Kaidanovich O. The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin Ther Targets 2002; 6: 555-561.
• Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378: 31-40.
• Fatima A, Agrawal P, Singh PP. Herbal option for diabetes: an overview. Asian Pac J Trop Dis 2012; 2: S536-S44.
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
• Rotenstein LS, Kozak BM, Shivers JP, Yarchoan M, Close J, Close KL. The ideal diabetes therapy: what will it look like? How close are we? Clin Diabetes 2012; 30: 44-53.
• Yusuff KB, Obe O, Joseph BY. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria. Pharm World Sci 2008; 30: 876-883.
• Andrade-Cetto A, Heinrich M. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J Ethnopharmacol 2005; 99: 325-348.
• Ezuruike UF, Prieto JM. The use of plants in the traditional management of diabetes in Nigeria: pharmacological and toxicological considerations. J Ethnopharmacol 2014; 155: 857-924.
• Eilerman RG. Cinnamic acid, cinnamaldehyde, and cinnamyl alcohol. In: Seidel A, editor. Kirk-Othmer Encyclopedia of Chemical Technology. 5th ed. New York, NY, USA: John Wiley & Sons, Inc.; 2001. pp. 595-603.
• Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727-747.
• Lee EJ, Kim SR, Kim J, Kim YC. Hepatoprotective phenylpropanoids from Scrophularia buergeriana roots against CCl4 -induced toxicity: action mechanism and structureactivity relationship. Planta Med 2002; 68: 407-411.
• Wiesner J, Mitsch A, Wissner P, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg Med Chem Lett 2001; 12: 423-424.
• Banskota AH, Nagaoka T, Sumioka LY, Tezuka Y, Awale S, Midorikawa K, Matsushige K, Kadota S. Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J Ethnopharmacol 2002; 80: 67-73.
• Cartron E, Carbonneau MA, Fouret G, Descomps B, Léger CL. Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production. J Nat Prod 2001; 64: 480-486.
• Taner G, Özkan Vardar D, Aydin S, Aytaç Z, Başaran A, Başaran N. Use of in vitro assays to assess the potential cytotoxic, genotoxic and antigenotoxic effects of vanillic and cinnamic acid. Drug Chem Toxicol 2017; 40: 183-190.
• Bickers D, Calow P, Greim H, Hanifin J, Rogers A, Saurat J, Sipes IG, Smith RL, Tagami H. A toxicologic and dermatologic assessment of cinnamyl alcohol, cinnamaldehyde and cinnamic acid when used as fragrance ingredients: the RIFM expert panel. Food Chem Toxicol 2005; 43: 799-836.
• Lenzen S. The mechanisms of alloxan-and streptozotocininduced diabetes. Diabetologia 2008; 51: 216-226.
• King AJ. The use of animal models in diabetes research. Br J Pharmacol 2012; 166: 877-894.
• Cumaoğlu A, Ozansoy G, Irat AM, Arıcıoğlu A, Karasu Ç, Arı N. Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats. Eur J Pharmacol 2011; 654: 80-85.
• Patel R, Shervington A, Pariente JA, Martinez‐Burgos MA, Salido GM, Adeghate E, Salido GM, Adeghate E, Singh J. Mechanism of exocrine pancreatic insufficiency in streptozotocin‐induced type 1 diabetes mellitus. Ann N Y Acad Sci 2006; 1084: 71-88.
• Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000; 35: 206-221.
• Bacanlı M, Aydın S, Taner G, Göktaş H, Şahin T, Başaran A, Başaran N. Does rosmarinic acid treatment have protective role against sepsis-induced oxidative damage in Wistar albino rats? Hum Exp Toxicol 2016; 35: 877-886.
• Sier C, Kubben F, Ganesh S, Heerding M, Griffioen G, Hanemaaijer R, van Krieken JH, Lamers CB, Verspaget HW. Tissue levels of matrix metalloproteinases MMP-2 and MMP9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74: 413-417.
• Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 2568-2569.
• Hsu CL, Yen GC. Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Mol Nutr Food Res 2008; 52: 53-61.
• Stalikas CD. Extraction, separation, and detection methods for phenolic acids and flavonoids. J Sep Sci 2007; 30: 3268-3295.
• Penckofer S, Schwertz D, Florczak K. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs 2002; 16: 68-85.
• Desco MC, Asensi M, Márquez R, Martínez-Valls J, Vento M, Pallardó FV, Sastre J, Viña J. Xanthine oxidase is involved in free radical production in type 1 diabetes protection by allopurinol. Diabetes 2002; 51: 1118-1124.
• Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000; 49: 1939-1945.
• Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25-28.
• Armstrong D, Al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med 1991; 11: 433-436.
• Rungby J, Flyvbjerg A, Andersen HB, Nyborg K. Lipid peroxidation in early experimental diabetes in rats: effects of diabetes and insulin. Acta Endocrinol 1992; 126: 378-380.
• Godin DV, Wohaieb SA. Reactive oxygen radical processes in diabetes. In: Singal PK, editor. Oxygen Radicals in the Pathophysiology of Heart Disease. Developments in Cardiovascular Medicine. 1st ed. Boston, MA, USA: Springer; 1988. pp. 303-322.
• Godin DV, Wohaieb SA, Garnett ME, Goumeniouk A. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol. Cell. Biochem 1988; 84: 223-231.
• Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi K, Amemiya S, Kato K, Nakazawa S. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radic Biol Med 1993; 15: 597-602.
• Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005; 36: 376-381.
• Adisakwattana S, Chantarasinlapin P, Thammarat H, YibchokAnun S. A series of cinnamic acid derivatives and their inhibitory activity on intestinal α-glucosidase. J Enzyme Inhib Med Chem 2009; 24: 1194-1200.
• Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol 2006; 104: 119-123.
• Ping H, Zhang G, Ren G. Antidiabetic effects of cinnamon oil in diabetic KK-Ay mice. Food Chem Toxicol 2010; 48: 2344- 2349.
• Huang DW, Shen SC, Wu JSB. Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. J Agric Food Chem 2009; 57: 7687-7692.
• Huang DW, Shen SC. Caffeic acid and cinnamic acid ameliorate glucose metabolism via modulating glycogenesis and gluconeogenesis in insulin-resistant mouse hepatocytes. J Funct Foods 2012; 4: 358-366.
• Rao BK, Rao CA. Hypoglycemic and antihyperglycemic activity of Syzygium alternifolium (Wt.) Walp. seed extracts in normal and diabetic rats. Phytomedicine 2001; 8: 88-93.
• Kasetti RB, Rajasekhar MD, Kondeti VK, Fatima SS, Kumar EGT, Swapna S, Ramesh B, Rao CA. Antihyperglycemic and antihyperlipidemic activities of methanol:water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats. Food Chem Toxicol 2010; 48: 1078-1084.
• Adisakwattana S, Moonsan P, Yibchok-Anun S. Insulinreleasing properties of a series of cinnamic acid derivatives in vitro and in vivo. J Agric Food Chem 2008; 56: 7838-7844.
• Babu PS, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde—a potential antidiabetic agent. Phytomedicine 2007; 14: 15-22.
• Lakshmi BS, Sujatha S, Anand S, Sangeetha KN, Narayanan RB, Katiyar C, Kanaujia A, Duggar R, Singh Y, Srinivas K. Cinnamic acid, from the bark of Cinnamomum cassia, regulates glucose transport via activation of GLUT4 on L6 myotubes in a phosphatidylinositol 3‐kinase‐independent manner. J Diabetes 2009; 1: 99-106.
• Yibchok‐anun S, Adisakwattana S, Moonsan P, Hsu WH. Insulin‐secretagogue activity of p‐methoxycinnamic acid in rats, perfused rat pancreas and pancreatic β‐cell line. Basic Clin Pharmacol Toxicol 2008; 102: 476-482.
• Kushwaha S, Vikram A, Trivedi P, Jena G. Alkaline, Endo III and FPG modified comet assay as biomarkers for the detection of oxidative DNA damage in rats with experimentally induced diabetes. Mutat Res Genet Toxicol Environ Mutagen 2011; 726: 242-250.